Abiraterone Acetate

Major

Abiraterone Acetate Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine exposure and reduced active metabolite (morphine) exposure Details Abiraterone Acetate Abametapir Explained Increased exposure of CYP3A4 substrate Details Abiraterone Acetate Acarbose Prandase® Explained An increased risk of severe hypoglycemia Details Abiraterone Acetate Apixaban Eliquis Explained Increased apixaban exposure Details Abiraterone Acetate Aripiprazole Injection Abilify Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate Alogliptin Nesina An increased risk of severe hypoglycemia Details Abiraterone Acetate Brexpiprazole Rexulti Increased brexpiprazole exposure Details Abiraterone Acetate Canagliflozin Invokana An increased risk of severe hypoglycemia Details Abiraterone Acetate Dabigatran Pradaxa® Increased dabigatran etexilate exposure Details Abiraterone Acetate Dabigatran Etexilate Increased dabigatran etexilate exposure Details Abiraterone Acetate Dapagliflozin Farxiga An increased risk of severe hypoglycemia Details Abiraterone Acetate Desloratadine Clarinex Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Abiraterone Acetate Deutetrabenazine Austedo Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate Doxorubicin Adriamycin Increased DOXOrubicin exposure Details Abiraterone Acetate Dulaglutide Injection Trulicity An increased risk of severe hypoglycemia Details Abiraterone Acetate Edoxaban Savaysa Increased edoxaban exposure Details Abiraterone Acetate Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) An increased risk of severe hypoglycemia Details Abiraterone Acetate Ertugliflozin Steglatro An increased risk of severe hypoglycemia Details Abiraterone Acetate Exenatide Injection Bydureon An increased risk of severe hypoglycemia Details Abiraterone Acetate Flecainide Tambocor® Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate Glimepiride Amaryl An increased risk of severe hypoglycemia Details Abiraterone Acetate Glipizide Glucotrol An increased risk of severe hypoglycemia Details Abiraterone Acetate Ifosfamide Injection Ifex Decreased ifosfamide effectiveness Details Abiraterone Acetate Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) An increased risk of severe hypoglycemia Details Abiraterone Acetate Insulin Detemir (Rdna Origin) Injection Levemir An increased risk of severe hypoglycemia Details Abiraterone Acetate Insulin Glulisine (Rdna Origin) Injection Apidra An increased risk of severe hypoglycemia Details Abiraterone Acetate Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Abiraterone Acetate Linagliptin Tradjenta An increased risk of severe hypoglycemia Details Abiraterone Acetate Liraglutide Injection Saxenda An increased risk of severe hypoglycemia Details Abiraterone Acetate Lixisenatide Injection Adlyxin® An increased risk of severe hypoglycemia Details Abiraterone Acetate Loperamide Diamode Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Abiraterone Acetate Lurasidone Latuda Increased lurasidone exposure Details Abiraterone Acetate Metformin Fortamet® An increased risk of severe hypoglycemia Details Abiraterone Acetate Mexiletine Mexitil® Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate Miglitol Glyset® An increased risk of severe hypoglycemia Details Abiraterone Acetate Montelukast Singulair Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Abiraterone Acetate Naloxegol Movantik Increased naloxegol exposure Details Abiraterone Acetate Nateglinide Starlix® An increased risk of severe hypoglycemia Details Abiraterone Acetate Nebivolol Bystolic Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate Ospemifene Osphena Increased ospemifene exposure and increased risk of adverse events Details